Robert M Reece, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 32 Quail Hollow Rd, North Falmouth, MA 02556 Phone: 508-540-0848 |
News Archive
The Beryl Companies, the nation's leading provider of outsourced call center services to healthcare organizations, has achieved a growth rate of 41 percent in the last three years, earning it a place in the prestigious Inc. 5000 list of the fastest-growing private companies in the country for the third straight year.
Researchers at the University of Maryland School of Medicine (UMSOM) have developed a novel technology to test for the presence of thin membrane protrusions called "microtentacles" on breast cancer cells, which can help predict whether a tumor is likely to spread.
UCLA researchers and colleagues have received a $13.65 million grant from the National Institutes of Health to investigate and further develop an immunotherapy known as CAR T, which uses genetically modified stem cells to target and destroy HIV.
Since its arrival in Haiti two years ago, "cholera has sickened more than 600,000 people and killed more than 7,500," and "[t]his year the epidemic is on track to be among the world's worst again, with nearly 77,000 cases and 550 deaths, according to the Haitian Ministry of Health," Ralph Ternier and Cate Oswald of Zanmi Lasante/Partners in Health in Haiti write in the Huffington Post's "Impact" blog.
Cerexa has announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation for PPI-0903, a next-generation, broad-spectrum, cephalosporin antibiotic, for the treatment of complicated skin and skin structure infections (cSSSI) caused by methicillin-resistant Staphylococcus aureus (MRSA).
› Verified 9 days ago